Mobile Optical Diagnostics: Ending the Multibillion-Dollar Emergency Vertigo Workup
Dr. Dereck Mush, MD, MBA
Viz.ai
Artificial intelligence software designed to detect strokes and vascular diseases in medical imaging scans.
What they do
The company develops cloud-based artificial intelligence algorithms that analyze CT scans for suspected large vessel occlusions and other acute conditions. It alerts specialists in real time to accelerate treatment decisions and coordinates care across hospital networks.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Clinical AI triage
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- San Francisco, USA
- Region
- North America
- Founded
- 2016
- Total funding
- $250M raised
Notable investors: Tiger Global Management, Insight Partners, Scale Venture Partners, Kleiner Perkins.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
De Novo AI in the Acute Care Pathway: How Queen of Hearts Redefines Emergency Triage Economics and Cath Lab Utilization
Dr. Dereck Mush, MD, MBA
Inside TumorSight Risk: What MRI-Based Recurrence Assessment Can and Cannot Tell Clinicians
Dr. Dereck Mush, MD, MBA
From IT Expense to Revenue Driver: How CMS NTAP Activates the Clinical AI Commercial Flywheel
Dr. Dereck Mush, MD, MBA